URL has been copied successfully!
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got some news and commentary from our Breakthrough Summit West to get into today.
The need-to-know this morning
- Parabilis Medicines has filed to go public under the symbol PBLS.
Former FDA chief is hopeful about agency’s new path
Former FDA commissioner David Kessler said he has “great confidence” in Kyle Diamantas, the new interim FDA chief after Marty Makary left the agency.
Please follow us:
